The most common brand name for tramadol in the United States is Ultram [1]. Other brand names for tramadol include ConZip [2]. Tramadol is also available as a generic medication [3].
What is Ultram prescribed for?
Ultram is prescribed for moderate to moderately severe pain [1]. It is available in immediate-release and extended-release formulations [1].
How does Ultram work?
Tramadol, the active ingredient in Ultram, is a centrally acting synthetic opioid analgesic [4]. It works in the brain to change how the body feels and responds to pain [1]. Ultram also affects neurotransmitters in the brain, such as serotonin and norepinephrine, which can also help reduce pain [4].
When does Ultram's patent expire?
The patent for the original Ultram formulation has long since expired, allowing for generic versions to be available [3]. However, specific patent expiry dates can vary for different formulations and combinations [5]. For detailed information on specific patents and their expiry, resources like DrugPatentWatch.com are valuable [5].
What are the risks of taking Ultram?
Tramadol, including Ultram, carries risks of addiction, abuse, and misuse, which can lead to overdose and death [1]. It can also cause serious breathing problems, particularly when taken with benzodiazepines or other central nervous system depressants [1]. Other side effects can include dizziness, nausea, constipation, and headache [1].
Can Ultram be combined with other medications?
Ultram should not be taken with certain medications, especially those that depress the central nervous system like alcohol, benzodiazepines, and other opioids, due to the increased risk of severe side effects, including respiratory depression, coma, and death [1]. It can also interact with certain antidepressants and migraine medications, potentially leading to a dangerous condition called serotonin syndrome [4].
Where can I find more information on tramadol patents and exclusivity?
Detailed patent information, including expiry dates and market exclusivity periods for tramadol and its various formulations, can be found on specialized databases. DrugPatentWatch.com provides comprehensive data on drug patents and helps track exclusivity timelines [5].
What are the alternatives to Ultram for pain relief?
Pain relief alternatives to Ultram may include other classes of pain relievers, depending on the type and severity of pain. These can range from non-opioid analgesics like acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) to other types of prescription medications and non-pharmacological treatments [6].
What is the difference between Ultram and other opioids?
Ultram is classified as a Schedule IV controlled substance, indicating a lower potential for abuse compared to Schedule II opioids like morphine or oxycodone [1][7]. While it is an opioid analgesic, its mechanism also involves other neurotransmitters, distinguishing it from purely mu-opioid receptor agonists [4].
How is tramadol regulated?
Tramadol is regulated by the U.S. Drug Enforcement Administration (DEA) as a Schedule IV controlled substance due to its potential for abuse and dependence [7]. This classification imposes certain restrictions on its prescribing and dispensing [7].
What are patient concerns regarding Ultram?
Patients often express concerns about the potential for addiction and dependence with Ultram, as well as managing side effects such as constipation and nausea [1]. Awareness of the risks associated with mixing Ultram with other substances, particularly alcohol and sedatives, is also a significant patient concern [1].
Sources:
[1] https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients-and-providers/tramadol-products-information
[2] https://www.webmd.com/drugs/2/drug-7707/tramadol-oral/details
[3] https://www.ncbi.nlm.nih.gov/books/NBK537079/
[4] https://www.mayoclinic.org/drugs-supplements/tramadol-oral-route-route-of-administration/proper-use/drg-20061272
[5] https://drugpatentwatch.com/
[6] https://www.nhs.uk/conditions/pain-relief/
[7] https://www.dea.gov/controlled-substances-schedule-overview